| Source: |
| Type: |
| Tyrosinase expression has been evaluated in various cancers—primarily melanoma—and its association with prognosis. Tyrosinase and Cancer — Melanocytic Lineage Enzyme, Differentiation Marker, and Selective Target Melanin Synthesis, Lineage Marker, and Therapeutic Handle – Tyrosinase is normally expressed in melanocytes and is generally maintained in melanomas. – Elevated tyrosinase expression in blood (detectable tyrosinase mRNA) has been correlated with advanced disease stage and the presence of micrometastases.
Direction of Regulation in Cancer
-Context-specific, but most informative in melanoma:
-Upregulated in differentiated melanocytic tumors
-Downregulated or lost in dedifferentiated, invasive, therapy-resistant melanoma states
Thus, tyrosinase is best read as a lineage/differentiation marker, not a universal oncogenic driver.
|
| Normal Healthy |
| 4858- | Uro, | The Metabolite Urolithin-A Ameliorates Oxidative Stress in Neuro-2a Cells, Becoming a Potential Neuroprotective Agent |
| - | in-vitro, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1160 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid